IL6 and plasma cell myeloma: Moreover, IL-6, in its capacity as a B-cell growth and differentiation factor, was implicated as a driver of neoplastic cell proliferation in hematopoietic dyscrasias including multiple myeloma and Castleman’s disease and other hypergammaglobulinemic conditions such as cardiac myxoma [8,9,10,11].